Form 4 for IMRX Immuneering Corp

Accepted 2021-08-04 00:00:00 ET · period of report 2021-08-03 · accession 0001104659-21-099733 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
D	2021-08-04	2021-08-03	IMRX	Hall Brett Matthew	CSO	P - Purchase	$15.00	+1,353	6,393	+27%	+$20.3K
D	2021-08-04	2021-08-03	IMRX	Hall Brett Matthew	CSO	C - Cnv Deriv	—	+5,040	5,040	New	—
DM	2021-08-04	2021-08-03	IMRX	Hall Brett Matthew	CSO	C - Cnv Deriv	—	-5,040	0	-100%	—

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Class A Common Stock	2021-08-03	P	A	1,353	$15.00	6,393	D	—	—
2	Common	Class A Common Stock	2021-08-03	C	A	5,040	—	5,040	D	—	—	(F1) Immediately prior to the closing of the Issuer's initial public offering, each share of preferred stock automatically converted into shares of the Issuer's Class A common stock on a one-for-one basis.
3	Derivative	Series A Preferred Stock	2021-08-03	C	D	1,636	—	0	D	— · — to —	1,636 Class A Common Stock	(F1) Immediately prior to the closing of the Issuer's initial public offering, each share of preferred stock automatically converted into shares of the Issuer's Class A common stock on a one-for-one basis.
4	Derivative	Series B Preferred Stock	2021-08-03	C	D	3,404	—	0	D	— · — to —	3,404 Class A Common Stock	(F1) Immediately prior to the closing of the Issuer's initial public offering, each share of preferred stock automatically converted into shares of the Issuer's Class A common stock on a one-for-one basis.